AGTC - Applied Genetic Technologies Corporation

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

5.00

0.00 (0.00%)

At close: 4:00PM EDT

Stock chart is not supported by your current browser

Previous Close	5.00
Open	5.05
Bid	3.85 x 1200
Ask	5.05 x 2000
Day's Range	4.92 - 5.05
52 Week Range	3.25 - 6.05
Volume	48,451
Avg. Volume	107,463

Market Cap	90.524M
Beta	2.53
PE Ratio (TTM)	N/A
EPS (TTM)	-0.61
Earnings Date	Feb 6, 2018 - Feb 12, 2018
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	8.00

Trade prices are not sourced from all markets

All

News

Press Releases

GlobeNewswire4 days ago
AGTC Doses First Patient in Phase 1/2 Clinical Study of Gene Therapy for the Treatment of X-Linked Retinitis Pigmentosa
Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that it has dosed the first patient in the Company’s Phase 1/2 clinical trial evaluating the safety and efficacy of an investigational AAV-based gene therapy for the treatment of X-linked retinitis pigmentosa (XLRP). The multicenter study will assess AGTC’s novel recombinant AAV vector expressing a human RPGR gene (the rAAV2tYF-GRK1-RPGR) in patients with XLRP. The patient is being followed by Dr. David Birch of Retina Foundation of the Southwest and the surgery was performed by Dr. Andreas Lauer of Oregon Health & Science University.
GlobeNewswire12 days ago
AGTC Announces Completion of Enrollment of Phase 1 / 2 Clinical Study of Investigational Gene Therapy in Patients with X-linked Retinoschisis (XLRS)
GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 10, 2018-- Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus- based gene therapies ...
GlobeNewswire2 months ago
AGTC Announces Sue Washer, CEO, Elected to Biotechnology Innovation Organization’s Board of Directors
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Feb. 14, 2018-- Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus- based gene therapies ...
ACCESSWIRE2 months ago
Wired News – Catalyst Biosciences Shares Positive Top-line Data from Phase-1/2 Study of Subcutaneous CB 2679d for Hemophilia B
Stock Monitor: Applied Genetic Technologies Post Earnings Reporting LONDON, UK / ACCESSWIRE / February 12, 2018 / Active-Investors.com has just released a free research report on Catalyst Biosciences, ...
Thomson Reuters StreetEvents2 months ago
Edited Transcript of AGTC earnings conference call or presentation 9-Feb-18 1:00pm GMT
Q2 2018 Applied Genetic Technologies Corp Earnings Call
Associated Press2 months ago
Applied Genetic Technologies posts 2Q loss
The Alachua, Florida-based company said it had a loss of 29 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
GlobeNewswire2 months ago
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2017
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 09, 2018-- Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus- based gene therapies ...
ACCESSWIRE2 months ago
Applied Genetic Technologies Corp. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 9, 2018 / Applied Genetic Technologies Corp. (NASDAQ: AGTC ) will be discussing their earnings results in their Q2 Earnings Call to be held on February 9, 2018 at 8:00 ...
GlobeNewswire3 months ago
AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 9, 2018
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 01, 2018-- Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus- based gene therapies ...
Capital Cube5 months ago
ETFs with exposure to Applied Genetic Technologies Corp. : December 1, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Applied Genetic Technologies Corp. Here are 5 ETFs with the largest exposure to AGTC-US. Comparing the performance and risk of Applied Genetic Technologies Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
Capital Cube5 months ago
Applied Genetic Technologies Corp. :AGTC-US: Earnings Analysis: Q1, 2018 By the Numbers : November 15, 2017
Categories: Yahoo FinanceGet free summary analysis Applied Genetic Technologies Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Applied Genetic Technologies Corp. – bluebird bio, Inc., Organovo Holdings, Inc., Eiger BioPharmaceuticals, Inc., Apollo Endosurgery, Inc. and Dicerna Pharmaceuticals, Inc. (BLUE-US, ONVO-US, EIGR-US, APEN-US and DRNA-US) ... Read more (Read more...)
Thomson Reuters StreetEvents5 months ago
Edited Transcript of AGTC earnings conference call or presentation 7-Nov-17 9:30pm GMT
Q1 2018 Applied Genetic Technologies Corp Earnings Call
Simply Wall St.5 months ago
Is Applied Genetic Technologies Corporation (AGTC) A Sell At Its Current Price?
Applied Genetic Technologies Corporation (NASDAQ:AGTC) is trading with a trailing P/E of 153.2x, which is higher than the industry average of 26.9x. While AGTC might seem like a stock toRead More...
Capital Cube7 months ago
ETFs with exposure to Applied Genetic Technologies Corp. : October 2, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Applied Genetic Technologies Corp. Here are 5 ETFs with the largest exposure to AGTC-US. Comparing the performance and risk of Applied Genetic Technologies Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
ACCESSWIRE7 months ago
Earnings Review and Free Research Report: Applied Genetic Announced Q4 and Full Year FY17 Results
LONDON, UK / ACCESSWIRE / October 2, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Applied Genetic Technologies Corp. (NASDAQ: AGTC ) ("Applied Genetic"), which ...
ACCESSWIRE7 months ago
Earnings Review and Free Research Report: Aviragen Reported its Q4 and Full Year FY17 Results
Research Desk Line-up: Applied Genetic Technologies Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 25, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on Aviragen Therapeutics, ...